GLOBAL WEARABLE DEVICE FOR MYOPIA CONTROL MARKET

INTRODUCTION

A cutting-edge solution to the problem of myopia or nearsightedness is a wearable gadget for myopia control. These tools, which frequently come in the shape of smart glasses or specialised contact lenses, make use of cutting-edge technology to control and slow the growth of myopia.

Wearable myopia control devices offer a proactive method of maintaining eye health by utilising features like changeable focus, customised vision correction, and real-time monitoring. These tools give users a practical solution to control their myopia while continuing to participate in their daily life because they may adjust to different activities and situations. These cutting-edge wearables considerably aid in fostering better eyesight for people of all ages as myopia rates continue to grow.

In order to actively stimulate the retina, the Wearable Device for Myopia Control projects myopically-defocused virtual pictures into the peripheral visual field using micro LEDs. This reduces the gradual lengthening of the eye in myopic patients. This device, which makes use of multifocal contact lens technology, uses light that has been myopically defocused by the non-central power of the contact lens to passively excite the entire peripheral retina.

The invention can also objectively and accurately generate the eye health indication result through a scientific calculation scheme, effectively improve eye habit, control the close distance and Duration, and manage enough outdoor time and frequency. It is more suitable for more perfect myopia prevention and control by the user wearing the device for a long time.

GLOBAL WEARABLE DEVICE FOR MYOPIA CONTROL MARKET SIZE AND FORECAST

The Global Wearable Device for Myopia Control market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.

RECENT PRODUCT DEVELOPMENT AND INNOVATION

A milestone was completed by Kubota Vision, a clinical-stage specialty ophthalmology business and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. The company created the first wearable prototype in the form of a pair of glasses using Kubota Glasses technology.

This product, which makes use of multifocal contact lens technology, uses light that has been myopically defocused by the contact lens' non-central power to passively excite the entire peripheral retina. With their electronic glasses-based Kubota Glasses technology, which uses nanotechnology, the company aims to slow the onset of myopia by actively stimulating the retina for shorter periods of time while retaining excellent central vision and not interfering with daily activities.

An exclusive licence agreement for SYD-101, Sydnexis' investigational proprietary low-dose atropine formulation, has been signed between Santen SA and Sydnexis Inc., a biopharmaceutical company focused on the development of treatments for the treatment of progressive myopia. SYD-101 is a 0.01% and 0.03% low-dose atropine sulphate ophthalmic solution under investigation that aims to increase treatment continuity by achieving efficacy, stability, and pain relief.

SYD-101 is an investigational low-dose atropine formulation built to be pharmacologically stable without requiring the pH to be lowered in order to reach a shelf life of up to three years at room temperature. This is due to its distinctive and proprietary formulation. 

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Wearable Device for Myopia Control are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a global Wearable Device for Myopia Control and key vendor selection criteria
3. Where are the Wearable Device for Myopia Control manufactured? What is the average margin per unit?
4. Market share of global Wearable Device for Myopia Control market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture global Wearable Device for Myopia Control in-house
6. key predictions for next 5 years in global Wearable Device for Myopia Control market
7. Average B-2-B Wearable Device for Myopia Control market price in all segments
8. Latest trends in Wearable Device for Myopia Control market, by every market segment
9. The market size (both volume and value) of the Wearable Device for Myopia Control market in 2023-2030 and every year in between?
10. Production breakup of Wearable Device for Myopia Control market, by suppliers and their OEM relationship